Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Perkins Discovery PDFDX
- NAV / 1-Day Return 40.13 / −0.20 %
- Total Assets 6.7 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.500%
- Distribution Fee Level High
- Share Class Type No Load
- Category Health
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield —
- Turnover 2%
USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:18 PM GMT+0
Morningstar’s Analysis PDFDX
Will PDFDX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 62.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
ePlus Inc | 9.42 | 718,560 | Technology |
Natera Inc | 9.04 | 689,040 | Healthcare |
Veracyte Inc | 7.58 | 577,710 | Healthcare |
Vericel Corp | 7.00 | 534,150 | Healthcare |
Perion Network Ltd | 6.27 | 478,485 | Communication Services |
ANI Pharmaceuticals Inc | 5.13 | 391,494 | Healthcare |
Option Care Health Inc | 4.86 | 370,590 | Healthcare |
NeoGenomics Inc | 4.67 | 355,960 | Healthcare |
Cantaloupe Inc | 4.18 | 318,630 | Technology |
Asure Software Inc | 4.12 | 314,160 | Technology |